Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays the recruitment status 'No longer looking for participants' and adds new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). The 'Intervention / Treatment' label has been updated to 'Intervention/Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check21 days agoChange DetectedThe revision indicator on the page updated from v3.5.4 to v3.5.5, signaling a minor update to the version history rather than a change to study content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision metadata was updated from v3.5.3 to v3.5.4, indicating a newer version of the page. This change reflects a backend update rather than a user-facing modification.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows a new site revision tag (v3.5.3) replacing the previous revision (v3.5.2), indicating a small platform update without changes to the study data or presentation.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.5.2 added. Revision: v3.5.0 removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.